Free Trial

Capital International Inc. CA Raises Stock Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Capital International Inc. CA raised its stake in shares of Genpact Limited (NYSE:G - Free Report) by 12.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 293,535 shares of the business services provider's stock after purchasing an additional 31,829 shares during the period. Capital International Inc. CA owned 0.17% of Genpact worth $12,607,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of G. SRH Advisors LLC acquired a new position in Genpact during the fourth quarter worth $26,000. Atlas Capital Advisors Inc. increased its position in Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the last quarter. Manchester Capital Management LLC acquired a new position in Genpact in the 4th quarter valued at about $38,000. GeoWealth Management LLC grew its stake in shares of Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after buying an additional 583 shares during the period. Finally, Smartleaf Asset Management LLC increased its stake in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after acquiring an additional 783 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Price Performance

G stock opened at $47.56 on Friday. The business's 50-day moving average is $50.52 and its two-hundred day moving average is $46.08. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The firm has a market capitalization of $8.35 billion, a P/E ratio of 16.75, a P/E/G ratio of 1.84 and a beta of 1.06. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.43%. The ex-dividend date of this dividend was Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is 23.94%.

Insider Buying and Selling at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 2.80% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have commented on G shares. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC raised their price target on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Genpact has a consensus rating of "Hold" and an average target price of $48.44.

View Our Latest Analysis on Genpact

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines